We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
776
DexCom
DXCM
$33.1B
| $1.35M | ﹤0.01% |
45,228
+26,616
| +143% | +$935K |
2018 Q4
1 quarter
|
|
|
ATH
777
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $1.32M | ﹤0.01% |
32,472
+24,109
| +288% | +$1.03M |
2018 Q2
3 quarters
|
|
778
Trimble
TRMB
$14.2B
| $1.3M | ﹤0.01% |
32,160
+18,975
| +144% | +$720K |
2018 Q2
3 quarters
|
|
779
Ares Management
ARES
$25.9B
| $1.3M | ﹤0.01% |
+56,000
| New | +$1.22M |
2019 Q1
0 quarters
|
|
|
HDS
780
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.27M | ﹤0.01% |
29,308
| – | – |
2018 Q2
3 quarters
|
|
781
DELISTED
Esperion Therapeutics
ESPR
| $1.25M | ﹤0.01% |
+31,264
| New | +$1.4M |
2019 Q1
0 quarters
|
|
782
Aecom
ACM
$7.6B
| $1.25M | ﹤0.01% |
42,258
+8,047
| +24% | +$241K |
2017 Q3
6 quarters
|
|
783
DELISTED
Liberty Broadband Class C
LBRDK
| $1.25M | ﹤0.01% |
13,630
+7,919
| +139% | +$674K |
2018 Q2
3 quarters
|
|
784
Ingredion
INGR
$6.13B
| $1.24M | ﹤0.01% |
13,130
+7,307
| +125% | +$690K |
2017 Q3
6 quarters
|
|
|
SINA
785
DELISTED
Sina Corp
SINA
| $1.24M | ﹤0.01% |
20,896
+5,123
| +32% | +$307K |
2017 Q3
6 quarters
|
|
786
Elanco Animal Health
ELAN
$11.8B
| $1.24M | ﹤0.01% |
+38,548
| New | +$1.19M |
2019 Q1
0 quarters
|
|
787
SiriusXM
SIRI
$9.15B
| $1.22M | ﹤0.01% |
21,475
+12,240
| +133% | +$730K |
2018 Q2
3 quarters
|
|
788
Kornit Digital
KRNT
$738M
| $1.21M | ﹤0.01% |
+51,047
| New | +$1.09M |
2019 Q1
0 quarters
|
|
789
Navient
NAVI
$897M
| $1.21M | ﹤0.01% |
104,839
-3,479
| -3% | -$39.8K |
2017 Q3
6 quarters
|
|
790
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.2M | ﹤0.01% |
79,243
+1,145
| +1% | +$16.7K |
2017 Q3
6 quarters
|
|
791
Old Dominion Freight Line
ODFL
$39.2B
| $1.2M | ﹤0.01% |
24,822
+15,036
| +154% | +$703K |
2018 Q2
3 quarters
|
|
792
DELISTED
SEMGROUP CORPORATION
SEMG
| $1.18M | ﹤0.01% |
80,200
| – | – |
2018 Q2
3 quarters
|
|
|
GWR
793
DELISTED
Genesee & Wyoming Inc.
GWR
| $1.18M | ﹤0.01% |
13,500
-2,900
| -18% | -$235K |
2018 Q2
3 quarters
|
|
794
RenaissanceRe
RNR
$14.3B
| $1.17M | ﹤0.01% |
8,147
+1,917
| +31% | +$268K |
2018 Q2
3 quarters
|
|
795
Live Nation Entertainment
LYV
$40.2B
| $1.16M | ﹤0.01% |
18,259
+10,508
| +136% | +$596K |
2018 Q2
3 quarters
|
|
796
Molina Healthcare
MOH
$11.1B
| $1.15M | ﹤0.01% |
+8,064
| New | +$1.09M |
2019 Q1
0 quarters
|
|
797
Sensata Technologies
ST
$6.01B
| $1.14M | ﹤0.01% |
+25,329
| New | +$1.2M |
2019 Q1
0 quarters
|
|
798
Vail Resorts
MTN
$5.45B
| $1.13M | ﹤0.01% |
5,193
+3,051
| +142% | +$623K |
2018 Q2
3 quarters
|
|
799
MasTec
MTZ
$15.4B
| $1.11M | ﹤0.01% |
23,000
-5,000
| -18% | -$225K |
2018 Q2
3 quarters
|
|
|
CHU
800
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $1.09M | ﹤0.01% |
85,300
-9,700
| -10% | -$115K |
2018 Q2
3 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.